1, To a tube add the following components:
* 5 ul of 200 ng/ul acceptor vector
* 10ul of Cre mix (1 ul Cre enzyme : 2 ul 10x Cre reaction buffer : 7 ul H2O)
* 5 ul of 200 ng/ul donor plasmid
2, Incubate at 37 oC for 30 min.
3, Heat inactive reaction for10 min at 70 ˚C.
4, Transform bacteria immediately or store at -20 oC.
10x Cre reaction buffer
330 mM NaCl
500 mM Tris-HCl pH 7.5
100 mM MgCl2
20 % PEG
Permalink
May 24, 2010 at 11:54 am
·
| Vector |
Promoter |
Selection |
Tags and Fusion partners |
Protease cleavage site |
Origin |
Supplier |
| pAcP(+)IE1-1 |
ie1 |
|
none |
none |
|
Novagen |
| pAcP(+)IE1-2 |
ie1 |
|
none |
none |
|
Novagen |
| pAcP(+)IE1-3 |
ie1 |
|
none |
none |
|
Novagen |
| pAcP(+)IE1-4 |
ie1 |
|
none |
none |
|
Novagen |
| pAcP(-)IE1-5 |
ie1 |
|
none |
none |
|
Novagen |
| pAcP(-)IE1-6 |
ie1 |
|
none |
none |
|
Novagen |
| pAcUW31 |
polh
p10 |
Amp |
none |
none |
pUC |
Clontech |
| pBAC-1 |
polh |
Amp |
C-His |
none |
|
Novagen |
| pBAC-2cp |
polh |
Amp |
N-His
C-His |
Thr
EK |
|
Novagen |
| pBAC-3 |
polh |
Amp |
signal sequence
N-His
C-His |
Thr
EK |
|
Novagen |
| pBAC4x-1 |
polh
p10 |
Amp |
none |
none |
|
Novagen |
| pBAC-7 |
polh |
Amp |
N-CBDclos
C-His |
Thr
EK |
|
Novagen |
| pBAC-8 |
polh |
Amp |
N-CBDclos
C-His |
Thr
Xa |
|
Novagen |
| pBAC-9 |
polh |
Amp |
C-CBDcex
C-His |
Thr |
|
Novagen |
| pBAC-10 |
polh |
Amp |
signal sequence
N-CBDcenD
C-His |
Thr
EK |
|
Novagen |
| pBacPAK8 |
polh |
Amp |
none |
none |
pUC |
Clontech |
| pBacPAK9 |
polh |
Amp |
none |
none |
pUC |
Clontech |
| pBACsurf-1 |
polh |
Amp |
signal sequence
C-gp64 |
none |
|
Novagen |
| pBlueBac4.5 |
polh |
Amp |
|
none |
pUC |
Invitrogen |
| pBlueBacHis2 |
polh |
Amp |
N-His |
EK |
pUC |
Invitrogen |
| pFastBac1 |
polh |
Amp
Gen |
none |
none |
|
Invitrogen |
| pFastBac HT |
polh |
Amp
Gen |
N-His |
TEV |
|
Invitrogen |
| pFastBac DUAL |
polh
p10 |
Amp
Gen |
none |
none |
|
Invitrogen |
| pMbac |
polh
p10 |
Amp |
signal sequence
(melittin) |
none |
|
Stratagene |
| pMelBac |
polh |
Amp |
secretion signal |
none |
pUC |
Invitrogen |
| pPbac |
polh
p10 |
Amp |
signal sequence
(alkaline phosphatase) |
none |
|
Stratagene |
| pTriEx-1 |
p10 |
Amp |
C-His |
none |
|
Novagen |
| pVL1392 |
polh |
Amp |
|
none |
ColE1 |
Invitrogen |
| pVL1393 |
polh |
Amp |
|
none |
ColE1 |
Invitrogen |
Permalink
May 17, 2010 at 10:26 pm
·
| Vector |
Promoter |
Selection |
Tags and Fusion partners |
Protease cleavage site |
Origin |
Supplier |
| pALTER-Ex1 |
T7 |
Tet |
none |
none |
|
Promega |
| pALTER-Ex2 |
T7 |
Tet |
none |
none |
|
Promega |
| pBAD/His |
araBAD |
Amp |
N-His |
EK |
pUC |
Invitrogen |
| pBAD/Myc-His |
araBAD |
Amp |
C-His |
none |
pUC |
Invitrogen |
| pBAD/gIII |
araBAD |
Amp |
leader sequence
C-His |
none |
ColE1 |
Invitrogen |
| pCal-n |
T7-lac |
Amp |
N-CBP |
Thr |
ColE1 |
Stratagene |
| pCal-n-EK |
T7-lac |
Amp |
N-CBP |
Thr
EK |
ColE1 |
Stratagene |
| pCal-c |
T7-lac |
Amp |
C-CBP |
Thr |
ColE1 |
Stratagene |
| pCal-Kc |
T7-lac |
Amp |
C-CBP |
Thr |
ColE1 |
Stratagene |
| pcDNA 2.1 |
T7 |
Amp |
none |
none |
pUC |
Invitrogen |
| pDUAL |
T7-lac |
Kan |
C-CBP |
Thr |
ColE1 |
Stratagene |
| pET-3a-c |
T7 |
Amp |
none |
none |
pBR322 |
Novagen |
| pET-9a-d |
T7 |
Kan |
none |
none |
pBR322 |
Novagen |
| pET-11a-d |
T7-lac |
Amp |
none |
none |
pBR322 |
Novagen |
| pET-12a-c |
T7 |
Amp |
none |
none |
pBR322 |
Novagen |
| pET-14b |
T7 |
Amp |
N-His |
Thr |
pBR322 |
Novagen |
| pET-15b |
T7-lac |
Amp |
N-His |
Thr |
pBR322 |
Novagen |
| pET-16b |
T7-lac |
Amp |
N-His |
Xa |
pBR322 |
Novagen |
| pET-17b |
T7 |
Amp |
none |
none |
pBR322 |
Novagen |
| pET-19b |
T7-lac |
Amp |
N-His |
EK |
pBR322 |
Novagen |
| pET-20b(+) |
T7 |
Amp |
signal sequence
C-His |
none |
pBR322 |
Novagen |
| pET-21a-d(+) |
T7-lac |
Amp |
C-His |
none |
pBR322 |
Novagen |
| pET-22b(+) |
T7-lac |
Amp |
signal sequence
C-His |
none |
pBR322 |
Novagen |
| pET-23a-d(+) |
T7 |
Amp |
C-His |
none |
pBR322 |
Novagen |
| pET-24a-d(+) |
T7-lac |
Kan |
C-His |
none |
pBR322 |
Novagen |
| pET-25b(+) |
T7-lac |
Amp |
signal sequence
C-His |
none |
pBR322 |
Novagen |
| pET-26b(+) |
T7-lac |
Kan |
Signal sequence
C-His |
none |
pBR322 |
Novagen |
| pET-27b(+) |
T7-lac |
Kan |
signal sequence
C-His |
none |
pBR322 |
Novagen |
| pET-28a-c(+) |
T7-lac |
Kan |
N-His
C-His |
Thr |
pBR322 |
Novagen |
| pET-29a-c(+) |
T7-lac |
Kan |
C-His |
Thr |
pBR322 |
Novagen |
| pET-30a-c(+) |
T7-lac |
Kan |
N-His
C-His |
Thr
EK |
pBR322 |
Novagen |
| pET-31b(+) |
T7-lac |
Amp |
C-His |
none |
pBR322 |
Novagen |
| pET-32a-c(+) |
T7-lac |
Amp |
internal His
C-His |
Thr
EK |
pBR322 |
Novagen |
| pET-33b(+) |
T7-lac |
Kan |
internal His
C-His |
Thr
EK |
pBR322 |
Novagen |
| pET-34b(+) |
T7-lac |
Kan |
N-CBDclos
C-His |
Thr
EK |
pBR322 |
Novagen |
| pET-35b(+) |
T7-lac |
Kan |
N-CBDclos
C-His |
Thr
Xa |
pBR322 |
Novagen |
| pET-36b(+) |
T7-lac |
Kan |
signal sequence
N-CBDcenA
C-His |
Thr
EK |
pBR322 |
Novagen |
| pET-37b(+) |
T7-lac |
Kan |
signal sequence
N-CBDcenA
C-His |
Thr
Xa |
pBR322 |
Novagen |
| pET-38b(+) |
T7-lac |
Kan |
signal sequence
C-CBDcex
C-His |
Thr |
pBR322 |
Novagen |
| pET-39b(+) |
T7-lac |
Kan |
(signal sequence)
DsbA
N-His
C-His |
Thr
EK |
pBR322 |
Novagen |
| pET-40b(+) |
T7-lac |
Kan |
(signal sequence)
DsbC
N-His
C-His |
Thr
EK |
pBR322 |
Novagen |
| pET-41a-c(+) |
T7-lac |
Kan |
GST
N-His
C-His |
Thr
EK |
pBR322 |
Novagen |
| pET-42a-c(+) |
T7-lac |
Kan |
GST
N-His
C-His |
Thr
Xa |
pBR322 |
Novagen |
| pET-43a-c(+) |
T7-lac |
Kan |
NusA
N-His
C-His |
Thr
EK |
pBR322 |
Novagen |
| pETBlue-1 |
T7-lac |
Amp |
C-His |
none |
pUC |
Novagen |
| pETBlue-2 |
T7-lac |
Amp |
C-His |
none |
pUC |
Novagen |
| pETBlue-3 |
T7-lac |
Amp |
N-His
C-His |
Thr
EK |
pUC |
Novagen |
| pGEMEX-1 |
T7 |
Amp |
T7 gene 10 |
none |
|
Promega |
| pGEMEX-2 |
T7 |
Amp |
T7 gene 10 |
none |
|
Promega |
| pGEX-1lT |
tac |
Amp |
GST |
Thr |
pBR322 |
Pharmacia |
| pGEX-2T |
tac |
Amp |
GST |
Thr |
pBR322 |
Pharmacia |
| pGEX-2TK |
tac |
Amp |
GST |
Thr
EK |
pBR322 |
Pharmacia |
| pGEX-3X |
tac |
Amp |
GST |
Xa |
pBR322 |
Pharmacia |
| pGEX-4T |
tac |
Amp |
GST |
Thr |
pBR322 |
Pharmacia |
| pGEX-5X |
tac |
Amp |
GST |
Xa |
pBR322 |
Pharmacia |
| pGEX-6P |
tac |
Amp |
GST |
Pre |
pBR322 |
Pharmacia |
| pHAT10/11/12 |
lac |
Amp |
N-HAT |
EK |
pUC |
Clontech |
| pHAT20 |
lac |
Amp |
N-HAT |
EK |
pUC |
Clontech |
| pHAT-GFPuv |
lac |
Amp |
N-HAT
N-GFPuv |
EK |
pUC |
Clontech |
| pKK223-3 |
tac |
Amp |
none |
none |
pBR322 |
Pharmacia |
| pLEX |
PL |
Amp |
none |
none |
pUC |
Invitrogen |
| pMAL-c2X |
tac |
Amp |
N-MBP |
Xa |
ColE1 |
NEB |
| pMAL-c2E |
tac |
Amp |
N-MBP |
EK |
ColE1 |
NEB |
| pMAL-c2G |
tac |
Amp |
N-MBP |
Gen |
ColE1 |
NEB |
| pMAL-p2X |
tac |
Amp |
N-MBP |
Xa |
ColE1 |
NEB |
| pMAL-p2E |
tac |
Amp |
N-MBP |
EK |
ColE1 |
NEB |
| pMAL-p2G |
tac |
Amp |
N-MBP |
Gen |
ColE1 |
NEB |
| pProEX HT |
trc |
Amp |
N-His |
TEV |
|
Invitrogen |
| pPROLar.A |
lac-ara1 |
Kan |
N-c-Myc |
EK |
p15A |
Clontech |
| pPROTet.E |
LtetO-1 |
Cam |
N-c-Myc |
EK |
ColE1 |
Clontech |
| pQE-9 |
T5-lac |
Amp |
N-His |
none |
ColE1 |
Qiagen |
| pQE-16 |
T5-lac |
Amp |
C-His |
none |
ColE1 |
Qiagen |
| pQE-30/31/32 |
T5-lac |
Amp |
N-His |
none |
ColE1 |
Qiagen |
| pQE-40 |
T5-lac |
Amp |
N-His
N-DHFR |
none |
ColE1 |
Qiagen |
| pQE-60 |
T5-lac |
Amp |
C-His |
none |
ColE1 |
Qiagen |
| pQE-70 |
T5-lac |
Amp |
C-His |
none |
ColE1 |
Qiagen |
| pQE-80/81/82L |
T5-lac |
Amp |
N-His |
none |
ColE1 |
Qiagen |
| pQE-100 |
T5-lac |
Amp |
N-His |
none |
ColE1 |
Qiagen |
| pRSET |
T7 |
Amp |
N-His |
EK |
ColE1 |
Invitrogen |
| pSE280 |
trc |
Amp |
none |
none |
pUC |
Invitrogen |
| pSE380 |
trc |
Amp |
none |
none |
pUC |
Invitrogen |
| pSE420 |
trc |
Amp |
none |
none |
pUC |
Invitrogen |
| pThioHis |
trc |
Amp |
His-Patch Trx |
EK |
ColE1 |
Invitrogen |
| pTrc99A |
trc |
Amp |
none |
none |
pBR322 |
Pharmacia |
| pTrcHis |
trc |
Amp |
N-His |
EK |
pUC |
Invitrogen |
| pTrcHis2 |
trc |
Amp |
C-His |
none |
pUC |
Invitrogen |
| pTriEx-1 |
T7 |
Amp |
C-His |
none |
pUC |
Novagen |
| pTriEx-2 |
T7-lac |
Amp |
N-His
C-His |
Thr
EK |
pUC |
Novagen |
| pTrxFus |
PL |
Amp |
Trx |
EK |
ColE1 |
Invitrogen |
Permalink
May 17, 2010 at 10:23 pm
·
There are 3 possible stop codons but TAA is preferred because it is less prone to read-through than TAG and TGA. The efficiency of termination is increased by using 2 or 3 stop codons in series.
Permalink
May 17, 2010 at 10:17 pm
·
The Shine-Dalgarno (SD) sequence is required or translation initiation and is complementary to the 3′-end of the 16S ribosomal RNA. The efficiency of translation initiation at the start codon depends on the actual sequence. The concensus sequence is: 5′-TAAGGAGG-3′. It is positioned 4-14 nucleotides upstream the start codon with the optimal spacing being 8 nucleotides. To avoid formation of secondary structures (which reduces expression levels) this region should be rich in A residues.
Permalink
May 17, 2010 at 10:15 pm
·